← All stocks

Neurogene Inc.

NGNE No buying or selling
CIK 0001404644 #2786 in the set updated 19 Sep 2026
Bought (1 mo)
$0.00
out of their own pocket, the only kind of buying there is
Sold (1 mo)
$0.00
$0.00 on a plan · $0.00 straight out of an exercise
Sold at will
$0.00
0 of 0 sales
Net
$0.00
$0.00 against sales at will

By person

5 insiders · 0 transactions
78.4×

Rachel McMinn holds 78.4 times base salary in stock. $48.58M of shares against $618.80K in salary for 2025.

Salary from the company's own proxy. The shares are what Rachel McMinn last reported holding, valued at $36.13, the price Common Stock was last bought or sold at on the open market here, on 7 Jul 2026.

Insider
Role
Bought
Sold
Net
Holding
Worth
Change
Samsara BioCapital GP, LLC entity
10% owner
1,717,127
$62.05M
+2.9%
McMinn Rachel
Chief Executive Officer
1,344,307
$48.58M
+7.5%
Cvijic Christine Mikail
President and CFO
84,040
$3.04M
+59.0%
Cobb Stuart
Chief Scientific Officer
30,497
$1.10M
+49.6%
Jordan Julie
Chief Medical Officer
12,472
$450.66K

No percentages here. These insiders hold more than one class of share between them, and the share count on file covers one of them rather than all. Dividing the two would compare different things.

Nothing of that kind in this period.

What was left out

Form 4 filings counted 0
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 0
Sales at will 0
Transactions with no price 0
Shares from compensation/vesting 0
History held since 21 Sep 2016